Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price was down 2.5% during trading on Tuesday . The stock traded as low as GBX 115 ($1.45) and last traded at GBX 117 ($1.48). Approximately 3,430 shares were traded during trading, a decline of 80% from the average daily volume of 17,071 shares. The stock had previously closed at GBX 120 ($1.52).
Arecor Therapeutics Stock Performance
The stock has a market cap of £35.84 million, a P/E ratio of -506.65 and a beta of -0.21. The company has a fifty day moving average of GBX 137.29 and a 200 day moving average of GBX 148.51. The company has a debt-to-equity ratio of 3.55, a current ratio of 2.17 and a quick ratio of 6.24.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Recommended Stories
- Five stocks we like better than Arecor Therapeutics
- 3 Monster Growth Stocks to Buy Now
- RXO Shares Surge Following New Acquisition Deal
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Golden Cross Stocks: Pattern, Examples and Charts
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
